Paper Details

  1. Home
  2. Paper Details

Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension.

Author: GeorgesGeorge, NayakAnjuli, QaqundahPaul, WeinsteinSteven

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Triamcinolone acetonide aqueous nasal spray offers a favorable efficacy to safety ratio for children aged 2 to 5 years with perennial allergic rhinitis.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Intranasal corticosteroids (INSs) are the most effective treatment for allergic rhinitis (AR). However, available INS safety and efficacy data in children younger than 6 years are limited. OBJECTIVE: To report the first well-controlled study assessing the safety and efficacy of an INS i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S1081-1206(10)60340-7

データ提供：米国国立医学図書館（NLM）

Triamcinolone Acetonide Nasal Spray: A Safe and Effective Treatment for Young Children with Allergies

Allergic rhinitis, a common condition that affects millions, can be particularly challenging for young children. This research, like a dedicated physician seeking solutions for the youngest patients, explores the safety and efficacy of triamcinolone acetonide aqueous nasal spray (TAA AQ) in children aged 2 to 5 years with perennial allergic rhinitis. The researchers conducted a comprehensive study, a double-blind, placebo-controlled trial, to assess the effectiveness and safety of this medication in this vulnerable age group.

A Safe and Effective Treatment: A Breath of Fresh Air for Children

The study's findings offer encouraging news for parents and caregivers seeking relief for their children's allergies. TAA AQ demonstrated a favorable safety profile and effectiveness in reducing symptoms of allergic rhinitis. The researchers observed a significant reduction in nasal symptom scores among children treated with TAA AQ, indicating its potential as a safe and effective treatment option.

Navigating Childhood Allergies: A Path to Relief

This research highlights the value of TAA AQ as a potential treatment option for young children with perennial allergic rhinitis. It provides parents and caregivers with valuable information about a safe and effective medication that can help alleviate their children's symptoms and improve their quality of life.

Dr. Camel's Conclusion

This study demonstrates that TAA AQ nasal spray can offer a safe and effective treatment for children aged 2 to 5 years with perennial allergic rhinitis, providing much-needed relief from allergy symptoms. The researchers' findings pave the way for improved treatment options and a brighter future for young children battling allergies.
Date :
  1. Date Completed 2009-06-12
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

19441606

DOI: Digital Object Identifier

10.1016/S1081-1206(10)60340-7

Related Literature

Article Analysis
・Effects of triamcinolone nasal spray
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.